Given the morphological and molecular similarities between SMARCA4-deficient thoracic tumors and U-CUP, we hypothesized that SMARCA4 deficiency may similarly predict ICI efficacy in CUP. The gene discussed is SMARCA4; the disease is neoplasm of thorax.